NSB
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
$0.0000
0.00%
Market cap
—
Turnover
—
Last price
$0.0000
Day change
0.00%
Announcements
9
Range, past year
Open 0.125 · Low 0.041 · Now 0.000 · High 0.260
Open NSB in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
NSB momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-11-16.
Trend stage
Neutral
1 Day
+0.0%
1 Week
+0.0%
1 Month
-11.5%
1 Year
-60.0%
RSI
41
Avg daily range
9.8%
Its trend is currently classified as Neutral.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -21.2%
- High volatility (ATR 9.8%)
- Risk rating: High
- Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsNSB announcements
Recent price-sensitive releases.
- 2026-10-27 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - First Quarter Activity Report | Commitments Test Entity - First Quarter Cashflow Report
- 2026-10-01 Leading CRO Appointed for Phase 2 Crohn's Trial Progress Report
- 2026-08-25 2026 Annual Report & Appendix 4E Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-28 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-05-26 Remarkable Results from Patients treated with StemSmart
- 2026-05-25 Trading Halt
- 2026-04-30 Quarterly Activities/Appendix 4C Cash Flow Report
More ASX stocks
Most traded in the same sector.
No other stocks on file for this sector.